Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Polymorphism
100%
Prognosis Prediction
100%
Systemic Sclerosis
100%
Interferon Regulatory Factor 5 (IRF5)
100%
SNP
30%
Minor Allele
30%
Scleroderma
30%
Interstitial Lung Disease
30%
Long-term Survival
20%
Forced Vital Capacity
20%
Genome-wide Association Study
20%
Promoter Region
10%
Major Histocompatibility Complex
10%
Single nucleotide Polymorphism
10%
Disease Pattern
10%
Disease Severity
10%
Age of Onset
10%
Gene Variants
10%
Transcript Level
10%
STAT4
10%
Complex Susceptibility
10%
Transcript Expression
10%
Susceptibility Loci
10%
Minor Allele Frequency
10%
Genome-wide Significance
10%
Johns Hopkins
10%
Independent Replication
10%
Anti-centromere Antibody
10%
Family Registry
10%
Anti-topoisomerase I Antibodies
10%
Autoantibody Profile
10%
Non-majors
10%
CD247
10%
Immunology and Microbiology
Systemic Scleroderma
100%
Interferon Regulatory Factor 5
100%
Single Nucleotide Polymorphism
40%
Allele
30%
Scleroderma
30%
Genome-Wide Association Study
20%
Forced Vital Capacity
20%
Replication
20%
Promoter Region
10%
Major Histocompatibility Complex
10%
Autoantibody
10%
STAT4
10%
Gene Frequency
10%
CD247
10%
Susceptibility
10%
Biochemistry, Genetics and Molecular Biology
IRF5
100%
Allele
30%
Single Nucleotide Polymorphism
30%
Forced Vital Capacity
20%
Genome-Wide Association Study
20%
Promoter Region
10%
Genetics
10%
Single-Nucleotide Polymorphism
10%
Major Histocompatibility Complex
10%
Autoantibody
10%
Minor Allele Frequency
10%
STAT4
10%
CD247
10%
Neuroscience
IRF5
100%
Genome-Wide Association Study
20%
Promoter Region
10%
Single-Nucleotide Polymorphism
10%
Major Histocompatibility Complex
10%
Allele Frequency
10%
Autoantibody
10%
STAT4
10%